Tender offer by Sanofi to acquire Ablynx

ACQUISITION

Sanofi’s offer to acquire Ablynx, a biopharmaceutical company engaged in the discovery and development of Nanobodies®

Summary of the Prospectus

  • Summary of the Prospectus - English version (please refer to the Prospectus which incorporates the Summary)
  • Summary of the Prospectus - Dutch version (please refer to the Prospectus which incorporates the Summary)
Summary of the Prospectus - French version

Acceptance and Withdrawal Forms

  • Acceptance and Withdrawal Forms - English version (please refer to the Prospectus which incorporates the Acceptance and Withdrawal Forms)
  • Acceptance and Withdrawal Forms - Dutch version (please refer to the Prospectus which incorporates the Acceptance and Withdrawal Forms)
Acceptance and Withdrawal Forms (French version)